Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7812595 | 0.85 | QPCT (0.38) | QPCTHSD17B10NFKB1QPCTLCYP19A1 | |
| SCHEMBL762773 | 0.81 | — | — | |
| SCHEMBL4267268 | 0.75 | — | — | |
| SCHEMBL25270 | 0.75 | QPCT (0.38) | QPCTHSD17B10NFKB1QPCTLCYP19A1 | |
| SCHEMBL28055211 | 0.73 | QPCT (0.36) | QPCTHSD17B10NFKB1QPCTLCYP19A1 | |
| SCHEMBL27889965 | 0.73 | — | — | |
| SCHEMBL255373 | 0.73 | — | — | |
| SCHEMBL13685027 | 0.73 | — | — | |
| SCHEMBL411098 | 0.73 | — | — | |
| SCHEMBL8296674 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12194448-B2 | Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same | THE GEORGE WASHINGTON UNIVERSITY (US) | 2025-01-14 | — | — | US | claimed |
| US-20200171474-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | THE GEORGE WASHINGTON UNIVERSITY | 2020-06-04 | — | — | US | claimed |
| WO-2018213821-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | THE GEORGE WASHINGTON UNIVERSITY (US) | 2018-11-22 | — | — | WO | claimed |
| WO-2008082224-A1 | WATER-SOLUBLE PHOTOINITIATORS | INKTEC CO., LTD. (KR) | 2008-07-10 | — | — | WO | claimed |
| US-12194448-B2 | Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same | THE GEORGE WASHINGTON UNIVERSITY (US) | 2025-01-14 | — | — | US | disclosed |
| US-20200171474-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | THE GEORGE WASHINGTON UNIVERSITY | 2020-06-04 | — | — | US | disclosed |
| WO-2018213821-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | THE GEORGE WASHINGTON UNIVERSITY (US) | 2018-11-22 | — | — | WO | disclosed |
| US-20150200422-A1 | ELECTROLYTE ADDITIVE FOR LITHIUM BATTERY, ELECTROLYTE INCLUDING THE SAME, AND LITHIUM BATTERY INCLUDING THE ELECTROLYTE | SAMSUNG SDI CO., LTD. (KR) | 2015-07-16 | — | — | US | disclosed |
| US-20130005739-A1 | PHARMACEUTICAL PREPARATIONS COMPRISING A COS RELEASING COMPOUND | LUDWIG BOLTZMANN CLUSTER FUER KARDIOVASKULAERE FORSCHUNG (AT) | 2013-01-03 | — | — | US | disclosed |
| EP-2343063-A1 | Pharmaceutical preparations comprising a COS releasing compound | Universität Wien (AT) | 2011-07-13 | — | — | EP | disclosed |
| WO-2008082224-A1 | WATER-SOLUBLE PHOTOINITIATORS | INKTEC CO., LTD. (KR) | 2008-07-10 | — | — | WO | disclosed |
| WO-2004101530-A1 | A METHOD FOR PRODUCING DIVERSE SET OF DITHIOATE COMPOUNDS | BIOORGANICS & APPLIED MATERIALS PVT LIMITED (IN) | 2004-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12194448-B2 | Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same | MLX, LDHA, CA2 | QPCT 1318/4885HSD17B10 299/4885NFKB1 4761/4885 |
| US-20130005739-A1 | PHARMACEUTICAL PREPARATIONS COMPRISING A COS RELEASING COMPOUND | VIP, CRH, ADCYAP1R1 | QPCT 1029/4885HSD17B10 537/4885NFKB1 1840/4885 |
| US-20200171474-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | MLX, LDHA, CA2 | QPCT 1318/4885HSD17B10 299/4885NFKB1 4761/4885 |
| US-20150200422-A1 | ELECTROLYTE ADDITIVE FOR LITHIUM BATTERY, ELECTROLYTE INCLUDING THE SAME, AND LITHIUM BATTERY INCLUDING THE ELECTROLYTE | CLIC1, LAGE3, LRRK2 | QPCT 4493/4885HSD17B10 330/4885NFKB1 2282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.